BioIncept LLC   Report issue

For profit Phase 2
Founded: Cherry Hill NJ United States (1996)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2014
NCT02239562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

BioIncept LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

synthetic preimplantation factor (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Graft vs Host Disease (Phase 1)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis, Autoimmune (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 1